Shanley S M, Chenevix-Trench G, Palmer J, Hayward N
Queensland Institute of Medical Research, Herston, Brisbane, Australia.
Carcinogenesis. 1995 Aug;16(8):2003-4. doi: 10.1093/carcin/16.8.2003.
The GSTM1 gene on chromosome 1p encodes the carcinogen-detoxification enzyme, glutathione S-transferase (mu subclass). The homozygous null genotype at this locus has been associated with increased susceptibility to malignancy, including some skin cancers. One hundred and twenty-four Australian patients with sporadic melanoma and 62 with familial basal cell carcinomas (a feature of nevoid basal cell carcinoma syndrome, NBCCS) were examined for germline homozygous deletions of GSTM1 using multiplex polymerase chain reactions. The homozygous null genotype was not overrepresented in either those with a single melanoma or in the NBCCS cases. Nor did it significantly accelerate tumorigenesis in either group. Analyses of much larger sample sizes will be required to investigate the representation of the null genotype in patients with multiple melanoma primaries and in those with melanoma co-existing with other non-cutaneous malignancies.
位于1号染色体短臂上的GSTM1基因编码致癌物解毒酶谷胱甘肽S-转移酶(μ亚类)。该基因座的纯合无效基因型与包括某些皮肤癌在内的恶性肿瘤易感性增加有关。采用多重聚合酶链反应对124例澳大利亚散发性黑色素瘤患者和62例家族性基底细胞癌患者(痣样基底细胞癌综合征,NBCCS的一种特征)进行了GSTM1基因纯合缺失检测。纯合无效基因型在单发黑色素瘤患者或NBCCS患者中均未过度出现。在这两组中,它也未显著加速肿瘤发生。需要分析更大样本量,以研究多原发性黑色素瘤患者以及合并其他非皮肤恶性肿瘤的黑色素瘤患者中无效基因型的表现情况。